Global Summit On Biosimilars
December 3 - 4, 2019 - Munich DE
The European Biosimilar Market is expected to grow robustly in the next five years. A significant number of blockbuster biologics are scheduled to lose patent protection before 2025, and as such will create huge opportunities for the entrance of biosimilar drugs across the continent. In light of these developments, C5 is pleased to present its inaugural Global Legal and Regulatory Summit on Biosimilars. Join us as we track the latest legal and regulatory ramifications for biosimilar stakeholders. Be part of interactive discussions that will enable you to develop a wholistic legal and regulatory strategy for maximising commercial results for your biosimilar products.